Liverpool Head and Neck Centre researchers awarded five cancer research grants totalling £5.7m
Liverpool Head and Neck Centre (LHNC) academics based at the University of Liverpool are leading on five new cancer research projects supported by £5.7m in funding.
These grants include clinical trials, laboratory investigations and exploring the interaction between head and neck cancer and SARS-CoV-2, the virus responsible for the COVID-19 pandemic.
This remarkable achievement is noteworthy during a period of concern about a paucity of research funding for Russell Group Universities. LHNC was created in 2018 as a partnership between University and NHS partners Liverpool University Hospitals NHS Foundation Trust, The Clatterbridge Cancer Centre NHS Foundation Trust and The Walton Centre NHS Foundation Trust, in order to facilitate treatment and research of diseases of the head and neck. Head and neck cancer is the 8th most common cancer in the UK and 6th most common globally.
Professor Terry Jones, Director of LHNC said: “The vision of LHNC has always been to embed translational research seamlessly into gold standard clinical care with the aim of improving the outcomes of head and neck cancer patients. This is of particular relevance in Liverpool which has a high level of socio-economic disadvantage and a disproportionate incidence of, and mortality from, head and neck cancer. This academic/ NHS synergy is now reaping considerable rewards in terms of research grant funding and we expect meaningful benefits for our patients to follow.”
LHNC is part of the newly established Liverpool Cancer Research Institute (LCRI), which functions as a translational research engine in which clinical themes provide a bi-directional conduit linking fundamental science, experimental medicine and clinical research. The LCRI encompasses all cancer research activity with UoL and all translational research in CCC
For more information click here
